6-K//Foreign company update
Universe Pharmaceuticals INC 6-K
Accession 0001213900-25-068704
$UPCCIK 0001809616other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 4:05 PM ET
Size
772.7 KB
Accession
0001213900-25-068704
Documents
- 6-Kea0250513-6k_universe.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
- EX-99.1ea025051301ex99-1_universe.htm
NOTICE AND PROXY STATEMENT OF 2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS, DATED JULY 29, 2025, TO BE MAILED TO THE SHAREHOLDERS OF THE COMPANY IN CONNECTION WITH THE 2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY
- EX-99.2ea025051301ex99-2_universe.htm
FORM OF PROXY CARD TO BE MAILED TO SHAREHOLDERS OF THE COMPANY FOR USE IN CONNECTION WITH THE 2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY
- GRAPHICex99-1_001.jpg
GRAPHIC
Issuer
Universe Pharmaceuticals INC
CIK 0001809616
Entity typeother
IncorporatedChina
Related Parties
1- filerCIK 0001809616
Filing Metadata
- Form type
- 6-K
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 4:05 PM ET
- Size
- 772.7 KB